title: What the future holds for gliptins.
abstract: Gliptins have revolutionised the treatment of Type 2 Diabetes Mellitus, addressing the hyperglycemia through its effects on the alpha and beta cells of the pancreas. In this article,we review the extra-glycemic effects of gliptins on central nervous system, cardiovascular biology and the bone health and concerns regarding pancreatitis and pancreatic cancer.
authors.affiliation: Apollo Centre for Obesity Diabetes and Endocrinology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, India.
authors.forename: Radhika
authors.initials: R
authors.lastname: Jindal
authors.forename: Ayesha
authors.initials: A
authors.lastname: Ahmad
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Siddiqui
authors.forename: Subhash K
authors.initials: SK
authors.lastname: Wangnoo
keywords: Gliptins; bone health; cancer
references.citation: Scand J Gastroenterol. 2002 Apr;37(4):392-8
references.pmid: 11989828
references.citation: Diabetes Care. 2008 Jan;31(1):30-5
references.pmid: 17947341
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23
references.pmid: 11502801
references.citation: J Clin Invest. 1989 May;83(5):1533-40
references.pmid: 2565342
references.citation: JAMA. 2004 Jan 21;291(3):335-42
references.pmid: 14734596
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):2027-31
references.pmid: 21734003
references.citation: Curr Pharm Des. 2011 Dec;17(38):4379-85
references.pmid: 22204436
references.citation: Diabetes Care. 2008 Jan;31(1):108-13
references.pmid: 17909087
references.citation: Endocr Relat Cancer. 2012 Sep 05;19(5):F77-88
references.pmid: 22691625
references.citation: Endocr Rev. 2012 Apr;33(2):187-215
references.pmid: 22323472
references.citation: Diabet Med. 2011 Oct;28(10):1176-81
references.pmid: 21923696